Sectors
NRIX
Nurix Therapeutics, Inc.
25.78
2 x 18.13
2 x 31.75
bid
ask
-
0.43
1.64%
2 @ 04:00 PM
25.78 +0.00 (0.00%)
| Ytd | 35.90% | |
| 1y | 176.02% |
25.17
day range
26.23
8.20
52 week range
28.23
| Open | 26.00 | Prev Close | 26.21 | Low | 25.17 | High | 26.23 | Mkt Cap | 2.68B |
| Vol | 1.11M | Avg Vol | 2.01M | EPS | -3.46 | P/E | N/A | Forward P/E | -17.92 |
| Beta | 1.79 | Short Ratio | 17.18 | Inst. Own | 113.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-08 | 50-d Avg | 24.40 | 200-d Avg | 18.64 | 1yr Est | 33.50 |
| Income Statement | |||
| Total Revenue | 9.04M | ||
| Revenues (USD) | 9.04M | ||
| Gross Profit | 9.04M | ||
| Operating Expenses | 103.25M | ||
| Research and Development Expense | 87.65M | ||
| Selling, General and Administrative Expense | 15.59M | ||
| Operating Income | -94.20M | ||
| Income Tax Expense | -271.00K | ||
| Net Income | -89.53M | ||
| Net Income Common Stock | -89.53M | ||
| Net Income Common Stock (USD) | -89.53M | ||
| Consolidated Income | -89.53M | ||
| Earnings per Basic Share | -0.81 | ||
| Earnings per Basic Share (USD) | -0.81 | ||
| Earnings per Diluted Share | -0.81 | ||
| Earning Before Interest & Taxes (EBIT) | -89.81M | ||
| Earning Before Interest & Taxes (USD) | -89.81M | ||
| Weighted Average Shares | 111.08M | ||
| Weighted Average Shares Diluted | 111.08M | ||
| Balance Sheet | |||
| Cash and Equivalents | 68.65M | ||
| Cash and Equivalents (USD) | 68.65M | ||
| Investments | 375.84M | ||
| Investments Current | 375.84M | ||
| Current Assets | 456.48M | ||
| Property, Plant & Equipment Net | 70.11M | ||
| Total Assets | 535.54M | ||
| Debt Current | 3.22M | ||
| Total Debt | 58.14M | ||
| Current Liabilities | 72.02M | ||
| Debt Non-Current | 54.92M | ||
| Total Liabilities | 132.91M | ||
| Accumulated Retained Earnings (Deficit) | -1.18B | ||
| Accumulated Other Comprehensive Income | -145.00K | ||
| Shareholders Equity | 402.63M | ||
| Shareholders Equity (USD) | 402.63M | ||
| Assets Non-Current | 79.06M | ||
| Total Debt (USD) | 58.14M | ||
| Deferred Revenue | 19.30M | ||
| Liabilities Non-Current | 60.89M | ||
| Trade and Non-Trade Payables | 12.21M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.85M | ||
| Net Cash Flow from Financing | 66.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.51M | ||
| Capital Expenditure | -1.94M | ||
| Issuance (Purchase) of Equity Shares | 66.00K | ||
| Net Cash Flow from Investing | 93.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 94.93M | ||
| Net Cash Flow from Operations | -96.57M | ||
| Share Based Compensation | 11.39M | ||